A citation-based method for searching scientific literature

Su-Jin Kim, Cuilan Nian, Doris J Doudet, Christopher H S McIntosh. Diabetes 2009
Times Cited: 76



Jun Shirakawa, Hideki Fujii, Kei Ohnuma, Koichiro Sato, Yuzuru Ito, Mitsuyo Kaji, Eri Sakamoto, Megumi Koganei, Hajime Sasaki, Yoji Nagashima, Kikuko Amo, Kazutaka Aoki, Chikao Morimoto, Eiji Takeda, Yasuo Terauchi. Diabetes 2011
Times Cited: 182




List of shared articles



Times cited


Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.
A E Hogan, A M Tobin, T Ahern, M A Corrigan, G Gaoatswe, R Jackson, V O'Reilly, L Lynch, D G Doherty, P N Moynagh,[...]. Diabetologia 2011
86

DPP-4 inhibitors: a patent review (2012 - 2014).
Roberto Costante, Azzurra Stefanucci, Simone Carradori, Ettore Novellino, Adriano Mollica. Expert Opin Ther Pat 2015
12


Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation.
Sun Woo Lim, Ji Zhe Jin, Long Jin, Jian Jin, Can Li. Korean J Intern Med 2015
5

DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
Fen Zhuge, Yinhua Ni, Mayumi Nagashimada, Naoto Nagata, Liang Xu, Naofumi Mukaida, Shuichi Kaneko, Tsuguhito Ota. Diabetes 2016
98



Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.
Xia Wang, Peilin Zheng, Gan Huang, Lin Yang, Zhiguang Zhou. Clin Exp Med 2018
16